Great Lakes Advisors LLC Invests $1.77 Million in Henry Schein, Inc. (HSIC)
Great Lakes Advisors LLC bought a new position in Henry Schein, Inc. (NASDAQ:HSIC) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 20,790 shares of the company’s stock, valued at approximately $1,768,000.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Aperio Group LLC lifted its holdings in Henry Schein by 0.9% in the third quarter. Aperio Group LLC now owns 66,209 shares of the company’s stock valued at $5,630,000 after acquiring an additional 621 shares during the period. Bridge Creek Capital Management LLC lifted its holdings in Henry Schein by 2.1% in the third quarter. Bridge Creek Capital Management LLC now owns 34,947 shares of the company’s stock valued at $2,971,000 after acquiring an additional 705 shares during the period. DekaBank Deutsche Girozentrale lifted its holdings in Henry Schein by 3.2% in the third quarter. DekaBank Deutsche Girozentrale now owns 23,050 shares of the company’s stock valued at $1,837,000 after acquiring an additional 705 shares during the period. Fuller & Thaler Asset Management Inc. lifted its holdings in Henry Schein by 57.1% in the second quarter. Fuller & Thaler Asset Management Inc. now owns 2,200 shares of the company’s stock valued at $160,000 after acquiring an additional 800 shares during the period. Finally, Kalos Management Inc. lifted its holdings in Henry Schein by 6.3% in the second quarter. Kalos Management Inc. now owns 13,615 shares of the company’s stock valued at $988,000 after acquiring an additional 807 shares during the period.
NASDAQ HSIC opened at $89.92 on Thursday. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.70 and a current ratio of 1.30. Henry Schein, Inc. has a 52 week low of $62.56 and a 52 week high of $91.35. The stock has a market capitalization of $13.71 billion, a PE ratio of 24.98, a P/E/G ratio of 2.96 and a beta of 0.89.
In related news, insider David Mckinley sold 8,321 shares of the stock in a transaction dated Friday, November 30th. The stock was sold at an average price of $88.77, for a total transaction of $738,655.17. Following the completion of the sale, the insider now owns 68,012 shares in the company, valued at $6,037,425.24. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Steven Paladino sold 21,110 shares of the stock in a transaction dated Monday, December 3rd. The stock was sold at an average price of $90.06, for a total value of $1,901,166.60. The disclosure for this sale can be found here. 1.15% of the stock is owned by company insiders.
HSIC has been the topic of a number of recent research reports. BidaskClub raised Henry Schein from a “buy” rating to a “strong-buy” rating in a report on Thursday, November 1st. Barrington Research increased their target price on Henry Schein from $92.00 to $96.00 and gave the company an “outperform” rating in a report on Thursday, November 8th. Morgan Stanley increased their target price on Henry Schein from $65.00 to $66.00 and gave the company an “underweight” rating in a report on Tuesday, October 9th. Goldman Sachs Group initiated coverage on Henry Schein in a report on Saturday, October 20th. They issued a “hold” rating and a $78.00 target price on the stock. Finally, Piper Jaffray Companies reissued an “overweight” rating and issued a $96.00 target price on shares of Henry Schein in a report on Thursday, November 29th. Two analysts have rated the stock with a sell rating, seven have issued a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $86.47.
About Henry Schein
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Further Reading: Why is the conference call important?
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.